We are live on ! Find out more
PCM

Palouse Capital Management Portfolio holdings

AUM $160M
1-Year Est. Return 36.15%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$1.45B
AUM Growth
+$1.27B
Cap. Flow
-$15.2M
Cap. Flow %
-1.05%
Top 10 Hldgs %
46.21%
Holding
87
New
9
Increased
10
Reduced
61
Closed
7

Top Sells

Rank Stock Value
1
MET icon
MetLife
MET
+$2.95M
2
IBM icon
IBM
IBM
+$2.79M
3
AMGN icon
Amgen
AMGN
+$2.42M
4
BLK icon
Blackrock
BLK
+$1.66M
5
NVR icon
NVR
NVR
+$1.02M

Sector Composition

Rank Sector Weight
1 Healthcare 26.16%
2 Technology 20.48%
3 Financials 14.14%
4 Consumer Discretionary 10.39%
5 Industrials 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
1
Regeneron Pharmaceuticals
REGN
$78.2B
$99.6M 6.89%
1,763
-553
-24% -$408K
BLK icon
2
Blackrock
BLK
$175B
$97.8M 6.76%
5,436
-2,479
-31% -$1.66M
AVGO icon
3
Broadcom
AVGO
$1.87T
$77.2M 5.34%
76,530
+64,380
+530% +$3.23M
TMO icon
4
Thermo Fisher Scientific
TMO
$213B
$76.1M 5.26%
2,024
-111
-5% -$58.8K
UNH icon
5
UnitedHealth
UNH
$377B
$73.2M 5.06%
5,860
-515
-8% -$273K
LRCX icon
6
Lam Research
LRCX
$369B
$58M 4.01%
60,620
+5,750
+10% +$241K
SPY icon
7
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$52.8M 3.65%
4,988
+428
+9% +$165K
GS icon
8
Goldman Sachs
GS
$303B
$47.4M 3.28%
7,432
-579
-7% -$202K
HD icon
9
Home Depot
HD
$339B
$43.6M 3.02%
8,693
-334
-4% -$102K
APD icon
10
Air Products & Chemicals
APD
$65.2B
$42.6M 2.94%
10,893
-1,083
-9% -$305K
VRTX icon
11
Vertex Pharmaceuticals
VRTX
$119B
$39.9M 2.76%
4,185
-281
-6% -$85.6K
BDX icon
12
Becton Dickinson
BDX
$46.9B
$35.1M 2.43%
3,710
-50
-1% -$11.8K
MSFT icon
13
Microsoft
MSFT
$3.62T
$33.1M 2.29%
18,675
-883
-5% -$212K
LOW icon
14
Lowe's Companies
LOW
$119B
$27.5M 1.9%
10,184
-627
-6% -$125K
JNJ icon
15
Johnson & Johnson
JNJ
$613B
$24.4M 1.69%
23,310
-1,468
-6% -$253K
UPS icon
16
United Parcel Service
UPS
$90.8B
$24M 1.66%
19,499
-1,157
-6% -$200K
FDX icon
17
FedEx
FDX
$73.2B
$23.9M 1.65%
11,613
-841
-7% -$140K
NXPI icon
18
NXP Semiconductors
NXPI
$56.5B
$21.8M 1.51%
15,629
-1,489
-9% -$236K
TGT icon
19
Target
TGT
$67.8B
$20.6M 1.42%
24,801
-1,673
-6% -$262K
WHR icon
20
Whirlpool
WHR
$2.54B
$19.5M 1.35%
13,466
-2,902
-18% -$413K
IBM icon
21
IBM
IBM
$213B
$19.5M 1.35%
3,638
-20,197
-85% -$2.79M
AAPL icon
22
Apple
AAPL
$4.46T
$17.9M 1.24%
17,138
-1,655
-9% -$237K
EOG icon
23
EOG Resources
EOG
$77.6B
$17.9M 1.24%
39,409
-2,004
-5% -$267K
VLO icon
24
Valero Energy
VLO
$88.5B
$17.5M 1.21%
18,532
-678
-4% -$85.1K
SDY icon
25
State Street SPDR S&P Dividend ETF
SDY
$23.6B
$17.3M 1.19%
+3,991
New +$493K

Similar funds

Palouse Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Palouse Capital Management held 87 positions worth $1.45B, up 722% from $176M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Palouse Capital Management's Q4 2022 filing shows 9 new, 10 increased, 61 reduced and 7 closed positions. Its largest new stake was State Street SPDR S&P Dividend ETF: 3,991 shares worth $17.3M. The largest sale was MetLife, an estimated $2.95M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

  • Palouse Capital Management's largest Q4 2022 buy was State Street SPDR S&P Dividend ETF: 3,991 shares worth $17.3M.
  • Palouse Capital Management added most to Broadcom in Q4 2022, an estimated $3.23M increase.
  • Palouse Capital Management's biggest Q4 2022 reduction was IBM, cutting an estimated $2.79M.
  • Palouse Capital Management fully exited MetLife in Q4 2022, selling an estimated $2.95M.
  • Palouse Capital Management's ten largest holdings make up 46% of its $1.45B portfolio in Q4 2022.
  • Palouse Capital Management opened 9 new positions and closed 7 in Q4 2022.
  • Palouse Capital Management's portfolio value rose 722% quarter-over-quarter to $1.45B.

Based on Palouse Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.